Herold Advisors’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $63.8K | Hold |
10,000
| – | – | 0.01% | 307 |
|
|
2025
Q1 | $48.6K | Hold |
10,000
| – | – | 0.01% | 280 |
|
|
2024
Q4 | $95.6K | Hold |
10,000
| – | – | 0.02% | 272 |
|
|
2024
Q3 | $83.5K | Hold |
10,000
| – | – | 0.02% | 268 |
|
|
2024
Q2 | $68.2K | Hold |
10,000
| – | – | 0.02% | 262 |
|
|
2024
Q1 | $25.3K | Hold |
10,000
| – | – | 0.01% | 264 |
|
|
2023
Q4 | $24K | Hold |
10,000
| – | – | 0.01% | 244 |
|
|
2023
Q3 | $34K | Hold |
10,000
| – | – | 0.01% | 246 |
|
|
2023
Q2 | $73.5K | Hold |
10,000
| – | – | 0.02% | 239 |
|
|
2023
Q1 | $104K | Buy |
+10,000
| New | +$104K | 0.04% | 226 |
|